Author | Celestia S. Higano, MD, FACP | OncLive

Author | Celestia S. Higano, MD, FACP


Dr. Higano on the State of Immunotherapy in Prostate Cancer

May 08, 2020


Celestia S. Higano, MD, FACP, discusses the state of immunotherapy in prostate cancer.

Intermittent Androgen Deprivation With the GnRH Antagonist Degarelix in Men With Biochemical Relapse of Prostate Cancer

January 03, 2016


Intermittent degarelix administered as described is noninferior to continuous androgen deprivation in maintaining PSA suppression, which indicates that degarelix is a suitable treatment option in men being considered for intermittent androgen ablation.